linkedin

Cell Line Development

Through
Cutting-Edge
Technology

Cell line development completes within 3 months generating high quality, high
titer clones

  • To fulfill your needs, we offer two options: Samsung proprietary cell line, S-CHOice®, and CHOZN
  • High titer of ~ 5g/L (mAb) results in cost saving in later stage of production
  • Lower lifetime costs through flexible licensing/pricing terms and no revenue dependent royalties
  • Titer and timeline are estimated based on past performance but may differ depending on client’s specific molecule and project requirements
  • Titer subject to project details

Single Cell Cloning With Beacon

Single cell cloning with Beacon TM image Single cell cloning with Beacon TM image
S-CHOice®

Samsung Biologics’ Super CHO cell
The Best Choice to start your therapeutics development journey

  • Delivers high productivity with 7+g/L titer
  • Maintains cell viability higher than 90% thru Day 21
s-choice image s-choice image
S-CHOice™

Samsung Biologics’ Super CHO cell
The Best Choice to start your therapeutics development journey

  • Delivers high productivity with 7+g/L titer
  • Maintains cell viability higher than 90% thru Day 21
s-choice image
s-choice image
Berkeley Light Beacon

fully automated live cell isolation, selection, and screening in nanopens

  • Screen 5,000 individual cells to find the best secretors
  • Efficient down selection on unstable clones
  • Automated monoclonality process with visual record at > 99%
  • Beacon is a registered trademark of Berkeley Lights, Inc.
Berkeley Light Beacon image Berkeley Light Beacon image

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved